Skip to main content
. 2022 Dec 6;11(23):3942. doi: 10.3390/cells11233942

Figure 12.

Figure 12

RIPOR2 expression in cervical premalignant lesions and cervical cancer. (A) RIPOR2 mRNA levels were analyzed by RT-qPCR using RIPOR2 pool primers in normal (n) HPV positive and negative samples, as well as LSIL and HSIL * p ≤ 0.0222; *** p = 0.0001. (B) Overall survival analysis comparing RIPOR2 low (blue line) vs. high (red line) expression in cervical cancer patients (p = 0.3306).